课题基金 / 基金详情

The mechanism of apoptosis induction by TGF-β stimuli and its clinical application

The mechanism of apoptosis induction by TGF-β stimuli and its clinical application
TGF-β刺激诱导细胞凋亡的机制及其临床应用
批准号:
13670157
负责人:
OSADA Hirotaka
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

OSADA Hirotaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We studied the mechanism of apoptosis induction by TGF-β stimuli for the purpose of applying in the cancer therapy. We established several apoptosis-inducible and -uninducible subclones derived from the single hepatoma cell line, which were partially sensitive to TGF-β stimuli. Our preliminary study using apoptosis-specific cDNA arrays showed that the expression of TNF family members were induced by TGF-β stimuli in the apoptosis-inducible subclones. We studied further the signaling pathways from TGF-β stimuli to apoptosis. After TGF-β stimuli, DNA contents, expression of TNF family, and activation of caspase family were sequentially studied. At first, the G1/G2 arrest was transiently observed, and then the induction of TNF family expression, caspase-8 activation, and apoptosis induction occurred sequentially. We studied the effects of neutralizing antibodies against TNF family members and caspase-8 inhibitor, Z-IETD-FMK against the apoptosis induction, and obtained about 50% inhibition of apoptosis. The NF- κB reporter analysis also showed the activation of NF-κB pathway by TGF-β stimuli. Our studies demonstrated the signaling pathway from TGF-β to apoptosis through TNF family induction and caspase-8 activation. Furhter studies using high-density cDNA array may be required to reveal the whole pathways of apoptosis induction. The activation of NF-κB might be associated with the TGF-β -resistance, but it remains to be determined.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
Osada H, Tatematsu Y, et al.: "Frequent and histological type-specific inactivation of 14-3-3s in human lung cancers"Oncogene. 21. 2418-2424 (2002)
Osada H、Tatematsu Y 等人:“人类肺癌中 14-3-3 的频繁和组织学类型特异性失活”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Osada H, Tatematsu Y, et al.: "Heterogeneous transforming growth factor (TGF)-b unresponsiveness and loss of TGF-b receptor type II expression caused by histone deacetylation in lung cancer cell lines"Cancer Research. 61. 8331-8339 (2001)
Osada H、Tatematsu Y 等人:“肺癌细胞系中组蛋白脱乙酰化引起的异质转化生长因子 (TGF)-b 无反应和 TGF-b 受体 II 型表达缺失”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y, and Takahashi T: "Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers"Oncogene. 21. 2328-2333 (2002)
Mizuno K、Osada H、Konishi H、Tatematsu Y、Yatabe Y、Mitsudomi T、Fujii Y 和 Takahashi T:“人类肺癌中 CHFR 前期检查点基因的异常高甲基化”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Konishi H, Osada H, et al.: "Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3ε At 17p13.3 in small cell lung cancers"Cancer Research. 62. 271-276 (2002)
Konishi H、Osada H 等人:“小细胞肺癌中频繁 G(2) 检查点损伤和 1​​4-3-3ε At 17p13.3 纯合缺失的鉴定”癌症研究。 62. 271-276 (2002) )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    Cell lineage-related mechanisms involved in lung cancer stem cell development.
    • 批准号:
      23501281
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2011
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    Investigation of epigenetic abnormalities involved in lung cancer progression.
    • 批准号:
      20590324
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    Molecular mechanisms of associations between abnormal differentiation and altered regulations of gene expressions.
    • 批准号:
      18590308
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.44万
    • 财政年份:
      2006
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    Alterations of Genome Network Regulations and Chromatin Configurations related to Carcinogenesis
    • 批准号:
      16590258
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2004
    • 负责人:
      OSADA Hirotaka
    • 依托单位:
    国内基金
    海外基金
    新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
    表观遗传调节因子BRD4调控TGF-β1相关纤维化基因和炎症因子参与腹膜透析相关性腹膜纤维化
    LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
    • 批准号:
      2026JJ82108
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谭亮
    • 依托单位:
    基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究